124 related articles for article (PubMed ID: 37587828)
21. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
22. Ethanol enhances naloxone sensitization and disrupts morphine discrimination--comparison to dizocilpine and pentobarbital: explanation of enhancing acute and attenuating chronic effects.
Kosten TA; Bombace JC
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1283-306. PubMed ID: 11474846
[TBL] [Abstract][Full Text] [Related]
23. Effects of MK 801 on morphine physical dependence: attenuation and intensification.
Koyuncuoğlu H; Dizdar Y; Aricioğlu F; Sayin U
Pharmacol Biochem Behav; 1992 Oct; 43(2):487-90. PubMed ID: 1438485
[TBL] [Abstract][Full Text] [Related]
24. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain.
Ghazal P; Ciccocioppo R; Ubaldi M
Peptides; 2013 Aug; 46():6-12. PubMed ID: 23684726
[TBL] [Abstract][Full Text] [Related]
25. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
26. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Fuertes G; Laorden ML; Milanés MV
Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
[TBL] [Abstract][Full Text] [Related]
27. The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat.
Murphy NP; Onaka T; Brown CH; Leng G
Neuroscience; 1997 Sep; 80(2):567-77. PubMed ID: 9284358
[TBL] [Abstract][Full Text] [Related]
28. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
Singh P; Sharma B; Gupta S; Sharma BM
Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
[TBL] [Abstract][Full Text] [Related]
29. Baclofen reestablishes micro-opioid receptor levels modified by morphine withdrawal syndrome in either sex.
Diaz SL; Kemmling AK; Bonavita CD; Rubio MC; Balerio GN
Synapse; 2004 Oct; 54(1):24-9. PubMed ID: 15300881
[TBL] [Abstract][Full Text] [Related]
30. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
31. Orexin type 1 receptor antagonism in Lateral Paragigantocellularis nucleus attenuates naloxone precipitated morphine withdrawal symptoms in rats.
Ahmadi-Soleimani SM; Ghaemi-Jandabi M; Azizi H; Semnanian S
Neurosci Lett; 2014 Jan; 558():62-6. PubMed ID: 24211689
[TBL] [Abstract][Full Text] [Related]
32. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal.
Kreeger JS; Yukhananov RYu ; Larson AA
Brain Res; 1994 Nov; 663(1):101-6. PubMed ID: 7850459
[TBL] [Abstract][Full Text] [Related]
33. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
34. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
35. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
Harris AC; Rothwell PE; Gewirtz JC
Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
[TBL] [Abstract][Full Text] [Related]
36. Morphine withdrawal increases intrinsic excitability of oxytocin neurons in morphine-dependent rats.
Brown CH; Stern JE; Jackson KL; Bull PM; Leng G; Russell JA
Eur J Neurosci; 2005 Jan; 21(2):501-12. PubMed ID: 15673449
[TBL] [Abstract][Full Text] [Related]
37. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
38. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
39. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
Schulteis G; Morse AC; Liu J
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
[TBL] [Abstract][Full Text] [Related]
40. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ
Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
